Source: International Congress 2014 – Systemic biomarkers for airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bulcun, M. Ekici, A. Ekici (Kirikkale, Turkey). Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease. Eur Respir J 2014; 44: Suppl. 58, 3999

Member's Comments

No comment yet.

Related content which might interest you: Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring comorbidities Year: 2016 LATE-BREAKING ABSTRACT: Multidimensional assessment of patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Predictors Year: 2014 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD) Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Pharmacological treatment of COPD in the on-sint cohort Source: International Congress 2014 – COPD exacerbations Year: 2014 Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Poor adherence to ICS treatment in patients with chronic respiratory diseases Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Changes in inhalation therapy after combined assessment of COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Nutritional status in chronic obstructive pulmonary disease Source: International Congress 2014 – Comorbidities Year: 2014 Diabetes mellitus and obstructive pulmonary disease. Is there an association? Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin Source: International Congress 2014 – Clinical presentations Year: 2014 Do GOLD stages of COPD severity really correspond to differences in health status? Source: Eur Respir J 2003; 22: 444-449 Year: 2003 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Patients’ adherence to chronic treatment of pulmonary diseases Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015